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Abstract
Epidemiological and experimental studies have led to the hypothesis of the fetal origin of adult diseases, suggesting that some 
adult diseases might be determined before birth by altered fetal development. Maternal diabetes subjects the fetus to an ad-
verse environment that has been demonstrated to result in metabolic, cardiovascular and renal impairment in the offspring. The 
growing amount of obesity in young females in developed and some developing countries should contribute to increasing the 
incidence of diabetes among pregnant women. In this review, we discuss how renal and extrarenal mechanisms participate in 
the genesis of hypertension induced by a diabetic status during fetal development.
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Increased blood pressure is the leading risk factor for heart 
disease, stroke and renal diseases. One of six people world-
wide is estimated to be hypertensive, and it is expected that 
this number will increase to 1.5 billion by 2025 (1). In Brazil, 
the prevalence of hypertension is estimated to be between 5 
and 30% depending on the area screened (2). The majority 
of the cases of hypertension are designated as essential 
or primary, with causes that are not defined (3). Increased 
evidence from both epidemiologic and experimental studies 
(4,5) has shown that alterations in the maternal environment 
can affect embryonic and fetal life, predisposing an individual 
to cardiovascular, metabolic and endocrine diseases in adult 
life. This concept has been known as prenatal programming 
or the Barker hypothesis (6,7).
In this review, we consider experimental results from 
studies performed mostly on rats and mice (8-11) to dis-
cuss how renal and extrarenal mechanisms participate in 
the genesis of hypertension induced by a diabetic status 
during fetal development.
Maternal diet
The relationship between prenatal insult, reduced 
nephron number and the development of hypertension was 
reported by Brenner et al. (12), who also suggested that 
food restriction could impair nephron formation, resulting 
in inappropriate sodium retention (12,13). Confirming this 
hypothesis, studies utilizing animal models were performed 
in which dams were subjected to a 50% restriction of food 
intake (14-16) or a low-protein diet during pregnancy 
(17,18). These studies provided evidence that the reduc-
tion in nephron number was associated with an increase in 
blood pressure in adult offspring (14-18). The mechanism 
responsible for the reduction in nephron formation is not 
completely known. Langley-Evans and McMullen (19) sug-
gested that the maternal diet can have an impact on cell 
proliferation and differentiation, reducing the cell number 
or changing the balance of cell types within tissues, lead-
ing to a subsequent alteration of physiological function. 
Woods et al. (20) reported that dietary protein restriction 
during pregnancy caused suppression of the intrarenal 
renin-angiotensin system in the offspring, a system that is 
essential for the normal development of the embryo. The 
exposure to glucocorticoids during fetal development, which 
affects tissue development and function, may also contrib-
ute to these changes considering that dams subjected to 
a low-protein diet during pregnancy had reduced activity 
and expression of 11β-hydroxysteroid dehydrogenase, 
the enzyme responsible for protecting the embryo from 
maternal corticoids (21). 
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Maternal diabetes mellitus
Nevertheless, the relationship concerning the prenatal 
insult due to maternal diabetes is still a matter of debate. 
Amri et al. (22) showed a decreased nephron number in 
the offspring of streptozotocin (STZ)-treated rat dams with 
induced diabetes at the beginning of pregnancy. In others 
studies, Rocha et al. (8) and Magaton et al. (9) examined 
the effect of diabetes mellitus induced in rats before mat-
ing, on the blood pressure and renal function of the adult 
offspring and observed development of hypertension 
without a reduction in nephron numbers. In the studies by 
our group (8-10,23), diabetes induction took place before 
pregnancy, preventing the effect of STZ on the development 
of the fetus. Moreover, in the studies by Amri et al. (22), the 
nephron count was performed using glomerular isolation. 
We used a methodology in which glomerular number is 
counted in 40 fields of kidney slides and glomerular diameter 
and area are calculated using a computer program. With 
another experimental protocol by Tran et al. (11), diabetes 
was induced in Hoxb7-Tg mice (transgenic mice in which a 
green fluorescent protein (GFP) is expressed in the ureteric 
bud under the control of the Hoxb7 promoter) on the 13th 
day of pregnancy. It was found that kidneys from neonate 
offspring of diabetic mothers had smaller glomeruli with 
a relative reduction in nephron number and with nephron 
collapse. Furthermore, the timing of the prenatal insult can 
affect kidney development in various ways. Ortiz et al. (24) 
treated rats with dexamethasone at different periods during 
pregnancy and did not observe reduction of glomerular 
number in all groups, suggesting that there are specific 
periods of gestation during which dexamethasone interferes 
with nephron formation. 
Glucocorticoids during pregnancy
During pregnancy, glucocorticoids are used to acceler-
ate fetal pulmonary maturation and to prevent respiratory 
distress syndrome (25). However, this treatment may have 
adverse effects on the developing fetus (26,27). In animal 
models, the administration of dexamethasone during preg-
nancy affected kidney development and caused hyperten-
sion (24,27,28). However, Ortiz et al. (24) observed that the 
offspring of dams treated with dexamethasone on the 13th 
and 14th days of pregnancy developed hypertension without 
a reduction in glomerular number, demonstrating that other 
factors besides the reduction in nephron number can be 
related to hypertension in prenatal insult models.
Renal sodium excretion
Renal sodium excretion is another important factor con-
tributing to the onset of hypertension. Rocco (29) studied the 
sodium excretion of diabetic offspring with and without so-
dium overload and observed that, under normal conditions, 
the offspring of diabetic mothers (DO) presented values of 
sodium excretion similar to control. However, after sodium 
overload, DO were unable to increase sodium excretion, 
as did the control group (Figure 1), and their hypertensive 
status was aggravated. Nehiri et al. (30) also examined the 
sodium excretion of DO that received a high-sodium diet for 
three consecutive days and observed that their increase in 
sodium excretion was significantly delayed compared to con-
trol. Moreover, the study of the renal cortex of DO revealed 
increased expression of epithelial sodium channel (ENaC) 
and sodium/potassium ATPase (Na+/K+ ATPase) without 
a decrease in the sodium/hydrogen exchanger (NHE3) or 
other sodium transporters, suggesting that sodium retention 
was due to increased reabsorption at the distal segments 
of the nephron (30).
Renin-angiotensin system
An imbalance of the renin-angiotensin system can also 
cause sodium retention in prenatally programmed hyper-
tensive rats. Wichi et al. (31) measured tissue angiotensin-
converting enzyme (ACE) activity in the heart, kidneys, 
liver, and lungs of DO and observed that ACE activity was 
enhanced in their hearts, kidneys, and lungs. The positive 
correlation between hypertension and increased ACE activ-
ity was first suggested by Blumenfeld (32), who reported 
that ACE had an important role in the pathophysiology of 
hypertension in diabetics (33). More recently, Sharifi et al. 
(34) demonstrated increased ACE activity in the kidneys, 
heart, lungs, and aorta of hypertensive two-kidney, one-
clip rats. 
Magaton et al. (9) analyzed the concentration of angio-
tensin in renal tissue from adult DO. Angiotensin II (ANG II) 
and other peptides produced by the renin system, i.e., ANG 
III, ANG 1-7, and ANG IV, have been reported to influence 
blood pressure by changing the arteriolar resistance (35). 
Particular attention has been focused on ANG 1-7 due to 
Figure 1. Fractional excretion of sodium (FE Na+) in rats submit-
ted to sodium overload (CS and DOS) or without sodium over-
load (C and DO). Data are reported as means ± SEM. C = con-
trol; DO = diabetic offspring. *P < 0.05 compared to C; **P < 0.05 
compared to CS (analysis of variance followed by the Bonferroni 
test). Reprinted, with permission, from Rocco (29).
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its action. Unlike ANG II, which causes va-
soconstriction, proliferation and hypertrophy, 
ANG 1-7 has been shown to have opposite 
effects, promoting vasodilatation and anti-
proliferation (36). In a study by Magaton et 
al. (9), the concentration of ANG II in renal 
tissue was similar in the control and DO 
groups, but the concentration of ANG 1-7 
was decreased in DO compared to control, 
a fact possibly indicating that changes in 
formation and/or degradation of ANG 1-7 had 
occurred. Corroborating these results, Chen 
et al. (37) recently observed that ACE2 gene 
expression was lower in the hypertensive DO 
than in control offspring. Considering that 
ACE2 is a protein involved in the formation 
of ANG 1-7 (38), its deficiency can be as-
sociated with reduced ANG 1-7 levels and 
development of hypertension in DO.
Nitric oxide system
Sodium retention in prenatally pro-
grammed hypertensive rats may also be 
the result of the imbalance of the nitric oxide 
(NO) system. In the kidney, NO has numer-
ous important functions including the regula-
tion of renal hemodynamics, maintenance 
of medullary perfusion, and modulation of 
tubuloglomerular feedback and tubular so-
dium reabsorption, resulting in a net effect 
of natriuresis and diuresis (39,40). 
Cavanal et al. (10) measured NO pro-
duction in aorta segments from DO and 
control rats using the fluorescent probe 
4,5-diaminofluorescein diacetate (DAF-2) 
and observed that basal NO production was 
significantly depressed in DO compared to 
control. After stimulation with acetylcholine 
(Ach) or bradykinin (BK), NO production 
increased significantly in all groups, but 
the increase was of a greater magnitude in 
the controls than in DO rats. In the DO rats 
supplemented with L-arginine, NO produc-
tion was significantly improved, suggesting 
that decreased substrate availability could 
contribute to the reduced NO production in 
this experimental model (Figure 2).
Under normal conditions, L-arginine 
levels in the plasma or in the vessels are 
above the metabolic requirements because 
they are in excess of the Km of NO synthase 
enzymes. In kidney disease, renal influx/production of 
L-arginine can be lower than normal, resulting in locally 
reduced production of NO. This could be valid in DO be-
cause an important decline in glomerular filtration rate was 
observed in several studies (8-10,23). Moreover, decreased 
renal ANG 1-7 content could also interfere with NO produc-
tion, as suggested by Li et al. (41). The authors observed 
Figure 2. Quantification of DAF-2 fluorescence and representative high power 
photomicrographs of the aortic rings (magnification 400X). A, Under basal condi-
tions; B, after stimulation with 0.1 mM acetylcholine, and C, after stimulation with 
0.1 mM bradykinin. Data are reported as means ± SEM; *P < 0.05 vs control, con-
trol plus L-arginine (L-arg) or diabetic plus L-arg (analysis of variance followed by 
the Bonferroni test). Reprinted, with permission, from Cavanal et al. (10).
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that the vasodilatory effect of ANG 1-7 in mouse aorta was 
completely abolished by pretreatment of the vessels with 
L-NAME and also in endothelium-denuded vessels, indicat-
ing that endothelial NO mediates the vasodilatory effect of 
ANG 1-7 in this model. 
Disarrangement in the NO system could also contribute 
to the development of hypertension due to the vascular ef-
fects. To study this issue, the vascular reactivity of DO was 
evaluated in the mesenteric bed of 12-month-old rats (8). 
The vasodilatory effect of Ach and BK on norepinephrine-
precontracted arteries was reduced in DO (Figure 3). 
However, the vasodilatory effect of nitroprusside was not 
impaired, suggesting that the occurrence of disturbances 
in NO production and/or sensitivity could be contributing 
to the hypertension observed in DO rats (8).
Metabolic abnormalities
In addition to the development of hypertension, offspring 
exposed to maternal diabetes during fetal life have been 
shown to present an increased risk for obesity and diabe-
tes mellitus type 2 (42,43). Silverman et al. (44) evaluated 
offspring from women with pregestational diabetes mellitus 
(type 1 or type 2) or gestational diabetes and observed that 
the prevalence of impaired glucose tolerance was signifi-
cantly increased in this group compared to control. Similar 
results were obtained by Pettitt et al. (45), who studied the 
effect of abnormal glucose tolerance on the offspring during 
pregnancy in Pima Indian women. The authors correlated 
the metabolic abnormalities existing in diabetic pregnancy 
to insulin resistance, obesity, and diabetes in the offspring 
(45). The mechanism by which maternal hyperglycemia in-
creases the risk of metabolic disarrangement in the offspring 
is not fully understood. It is possible that the increased offer 
of glucose to the fetus could act as a stimulus to enhance 
insulin production and expose the fetus to hyperinsuline-
mia (43,44). The increase in fetal leptin production can 
also contribute to the metabolic disarrangement (46,47). 
Increased concentrations of hormones, such as insulin 
and leptin, at critical periods of development can work as 
“endogenous functional teratogens” (48). For example, 
offspring from hyperglycemic rats develop a “malprogram-
ming” of hypothalamic neuropeptidergic neurons, causing 
an increase of orexigenic neuropeptide Y and Agouti-related 
protein, which could lead to hyperphagia and increased 
weight gain (49).
The insulin overproduction observed during the neonatal 
period can also be related to the development of cardiovas-
cular disturbances during adult age (42,50,51). Besides the 
effect of insulin on carbohydrate metabolism, this hormone 
presents several actions, including the modification of lipid 
and protein metabolism, ion and amino acid transport, cell 
cycle and proliferation, cell differentiation, apoptosis, and NO 
synthesis (52-54). In addition, insulin and other hormones, 
such as ANG II and norepinephrine, can influence each 
other (55-57). ANG II impairs the insulin signaling pathway 
through the SOCS 3 protein. ANG II acting throughout the 
AT1 receptor decreases insulin-induced NO production 
due to ERK 1/2 and JNK activation (56). Moreover, ANG 
II via the AT1 receptor enhances NADPH oxidase activity, 
increasing reactive oxygen species (ROS) generation (58). 
Recently, Zhou et al. (59) showed that up-regulation of ANG 
II and oxidative stress were associated with endothelial 
dysfunction and insulin resistance in hypertensive Dahl 
salt-sensitive rats. ROS may affect vascular function: a) 
directly on endothelial cells and vascular smooth muscle 
cells, resulting in structural and functional damage; b) by 
scavenging or inactivating endothelium-relaxing factors, 
such as NO or prostacyclin, and c) by producing peroxyni-
trite, a potent constrictor and lipid-oxidizing radical (60,61). 
Taking into account the multiple relationships between hor-
mones, intracellular messengers and vascular mediators, 
Figure 3. Changes on vascular diameter of the mesenteric arterial bed. Maternal diabetes caused an impaired response to endothe-
lium-dependent agents. Bar graphs show the response of the mesenteric microvessels to A, acetylcholine (300 µg/mL); B, bradykinin 
(3.0 µg/mL) and C, sodium nitroprusside (1.0 mg/mL) in control (C, open bars, N = 6) and diabetic offspring (DO, filled bars, N = 9) 
groups. Data are reported as means ± SEM of percent change. *P < 0.05 compared to control (analysis of variance followed by the 
Bonferroni test). Reprinted, with permission, from Rocha et al. (8).
Maternal diabetes and offspring hypertension 903
www.bjournal.com.br Braz J Med Biol Res 44(9) 2011
 1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton 
PK, He J. Global burden of hypertension: analysis of world-
wide data. Lancet 2005; 365: 217-223.
 2. Passos VMA, Assis TD, Barreto SM. Hypertension in Brazil: 
estimates from population-based prevalence studies. Epide-
miol Serviços Saúde 2006; 15: 35-45.
 3. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins & Cotran 
pathologic basis of disease. 8th edn. Philadelphia: Saun-
ders/Elsevier; 2010.
 4. Aerts L, Van Assche FA. Intra-uterine transmission of dis-
ease. Placenta 2003; 24: 905-911.
 5. Roseboom TJ, van der Meulen JH, Osmond C, Barker DJ, 
Ravelli AC, Schroeder-Tanka JM, et al. Coronary heart dis-
ease after prenatal exposure to the Dutch famine, 1944-45. 
Heart 2000; 84: 595-598.
 6. Barker DJ. In utero programming of chronic disease. Clin Sci 
1998; 95: 115-128.
 7. Barker DJ, Bagby SP, Hanson MA. Mechanisms of disease: 
in utero programming in the pathogenesis of hypertension. 
Nat Clin Pract Nephrol 2006; 2: 700-707.
 8. Rocha SO, Gomes GN, Forti AL, do Carmo Pinho FM, Fortes 
ZB, de Fatima CM, et al. Long-term effects of maternal dia-
betes on vascular reactivity and renal function in rat male 
offspring. Pediatr Res 2005; 58: 1274-1279.
 9. Magaton A, Gil FZ, Casarini DE, Cavanal MF, Gomes GN. 
Maternal diabetes mellitus - early consequences for the 
offspring. Pediatr Nephrol 2007; 22: 37-43.
10. Cavanal MF, Gomes GN, Forti AL, Rocha SO, Franco MC, 
Fortes ZB, et al. The influence of L-arginine on blood pres-
sure, vascular nitric oxide and renal morphometry in the 
offspring from diabetic mothers. Pediatr Res 2007; 62: 145-
150.
11. Tran S, Chen YW, Chenier I, Chan JS, Quaggin S, Hebert 
MJ, et al. Maternal diabetes modulates renal morphogenesis 
in offspring. J Am Soc Nephrol 2008; 19: 943-952.
12. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood 
pressure. Less of one, more the other? Am J Hypertens 
1988; 1: 335-347.
13. Brenner BM, Chertow GM. Congenital oligonephropathy 
and the etiology of adult hypertension and progressive renal 
injury. Am J Kidney Dis 1994; 23: 171-175.
14. Lucas SR, Costa Silva V, Miraglia SM, Zaladek GF. Func-
tional and morphometric evaluation of offspring kidney after 
intrauterine undernutrition. Pediatr Nephrol 1997; 11: 719-
723.
15. Regina S, Lucas R, Miraglia SM, Zaladek GF, Machado CT. 
Intrauterine food restriction as a determinant of nephroscle-
rosis. Am J Kidney Dis 2001; 37: 467-476.
16. Gil FZ, Lucas SR, Gomes GN, Cavanal MF, Coimbra TM. 
Effects of intrauterine food restriction and long-term dietary 
supplementation with L-arginine on age-related changes in 
renal function and structure of rats. Pediatr Res 2005; 57: 
724-731.
17. Langley-Evans SC, Welham SJ, Jackson AA. Fetal exposure 
to a maternal low protein diet impairs nephrogenesis and 
promotes hypertension in the rat. Life Sci 1999; 64: 965-
974.
18. Mesquita FF, Gontijo JA, Boer PA. Maternal undernutrition 
and the offspring kidney: from fetal to adult life. Braz J Med 
Biol Res 2010; 43: 1010-1018.
19. Langley-Evans SC, McMullen S. Developmental origins of 
adult disease. Med Princ Pract 2010; 19: 87-98.
20. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Ma-
ternal protein restriction suppresses the newborn renin-
angiotensin system and programs adult hypertension in rats. 
Pediatr Res 2001; 49: 460-467.
21. Langley-Evans SC. Developmental programming of health 
and disease. Proc Nutr Soc 2006; 65: 97-105.
22. Amri K, Freund N, Vilar J, Merlet-Benichou C, Lelievre-
Pegorier M. Adverse effects of hyperglycemia on kidney 
development in rats: in vivo and in vitro studies. Diabetes 
1999; 48: 2240-2245.
23. Rocco L, Gil FZ, da Fonseca Pletiskaitz TM, de Fatima CM, 
Gomes GN. Effect of sodium overload on renal function of 
offspring from diabetic mothers. Pediatr Nephrol 2008; 23: 
2053-2060.
24. Ortiz LA, Quan A, Zarzar F, Weinberg A, Baum M. Prenatal 
dexamethasone programs hypertension and renal injury in 
the rat. Hypertension 2003; 41: 328-334.
25. Effect of corticosteroids for fetal maturation on perinatal out-
comes. NIH Consensus Development Panel on the Effect of 
Corticosteroids for Fetal Maturation on Perinatal Outcomes. 
JAMA 1995; 273: 413-418.
26. Reinisch JM, Simon NG, Karow WG, Gandelman R. Prena-
tal exposure to prednisone in humans and animals retards 
intrauterine growth. Science 1978; 202: 436-438.
27. Celsi G, Kistner A, Aizman R, Eklof AC, Ceccatelli S, de 
Santiago A, et al. Prenatal dexamethasone causes oligo-
nephronia, sodium retention, and higher blood pressure in 
the offspring. Pediatr Res 1998; 44: 317-322.
References
the coexistence of hypertension and glucose intolerance 
is expected. 
Conclusions
The exact mechanism involved in the onset of systemic 
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mental model and reinforce the need for close monitoring 
of hyperglycemia during pregnancy to avoid permanent 
changes in offspring homeostasis.
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